| Product NDC: | 0006-0705 |
| Proprietary Name: | NOROXIN |
| Non Proprietary Name: | Norfloxacin |
| Active Ingredient(s): | 400 mg/1 & nbsp; Norfloxacin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0006-0705 |
| Labeler Name: | Merck Sharp & Dohme Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019384 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19861031 |
| Package NDC: | 0006-0705-20 |
| Package Description: | 20 TABLET, FILM COATED in 1 BOTTLE (0006-0705-20) |
| NDC Code | 0006-0705-20 |
| Proprietary Name | NOROXIN |
| Package Description | 20 TABLET, FILM COATED in 1 BOTTLE (0006-0705-20) |
| Product NDC | 0006-0705 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Norfloxacin |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 19861031 |
| Marketing Category Name | NDA |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | NORFLOXACIN |
| Strength Number | 400 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |